great read! Did anyone notice PAR mentioned a few times something to the effect that this peer review result should attract the interest of big pharma. Almost like they were soliciting interest. I thought the plan was to go it alone as far as we could. Thoughts?
Ann: Osteoarthritis pain reduced by Paradigms Zilosul (PPS), page-3
-
- There are more pages in this discussion • 53 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.5¢ |
Change
0.005(2.27%) |
Mkt cap ! $80.45M | |||
| Open | High | Low | Value | Volume |
| 22.5¢ | 23.0¢ | 22.5¢ | $11.49K | 50.47K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 152520 | 22.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.0¢ | 1951 | 2 |
View Market Depth
| Last trade - 11.16am 15/08/2024 (20 minute delay) ? |
| PAR (ASX) Chart |